nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100B—coronary artery disease	0.519	1	CbGaD
Olopatadine—CYP3A4—Ticagrelor—coronary artery disease	0.0232	0.146	CbGbCtD
Olopatadine—CYP3A4—Fenofibrate—coronary artery disease	0.0207	0.13	CbGbCtD
Olopatadine—CYP3A4—Gemfibrozil—coronary artery disease	0.0166	0.104	CbGbCtD
Olopatadine—CYP3A4—Clopidogrel—coronary artery disease	0.0144	0.0905	CbGbCtD
Olopatadine—CYP3A4—Eplerenone—coronary artery disease	0.0134	0.0841	CbGbCtD
Olopatadine—CYP3A4—Enalapril—coronary artery disease	0.0119	0.075	CbGbCtD
Olopatadine—CYP3A4—Rosuvastatin—coronary artery disease	0.00926	0.0583	CbGbCtD
Olopatadine—CYP3A4—Ezetimibe—coronary artery disease	0.00926	0.0583	CbGbCtD
Olopatadine—CYP3A4—Simvastatin—coronary artery disease	0.0086	0.0542	CbGbCtD
Olopatadine—CYP3A4—Pravastatin—coronary artery disease	0.00842	0.053	CbGbCtD
Olopatadine—CYP3A4—Lovastatin—coronary artery disease	0.00842	0.053	CbGbCtD
Olopatadine—CYP3A4—Atorvastatin—coronary artery disease	0.00767	0.0483	CbGbCtD
Olopatadine—CYP3A4—Losartan—coronary artery disease	0.00701	0.0442	CbGbCtD
Olopatadine—S100B—artery—coronary artery disease	0.00557	0.161	CbGeAlD
Olopatadine—S100A1—cardiac ventricle—coronary artery disease	0.00362	0.104	CbGeAlD
Olopatadine—S100A1—myocardium—coronary artery disease	0.0034	0.0981	CbGeAlD
Olopatadine—S100A13—Captopril—Enalapril—coronary artery disease	0.00238	0.766	CbGdCrCtD
Olopatadine—S100A1—heart—coronary artery disease	0.00238	0.0685	CbGeAlD
Olopatadine—S100A1—cardiovascular system—coronary artery disease	0.00224	0.0646	CbGeAlD
Olopatadine—S100A13—heart—coronary artery disease	0.00211	0.0608	CbGeAlD
Olopatadine—S100A12—heart—coronary artery disease	0.00208	0.0599	CbGeAlD
Olopatadine—S100B—heart—coronary artery disease	0.00205	0.0592	CbGeAlD
Olopatadine—S100A1—cardiac atrium—coronary artery disease	0.00203	0.0586	CbGeAlD
Olopatadine—S100A13—cardiovascular system—coronary artery disease	0.00199	0.0573	CbGeAlD
Olopatadine—S100A12—cardiovascular system—coronary artery disease	0.00196	0.0566	CbGeAlD
Olopatadine—S100B—cardiovascular system—coronary artery disease	0.00194	0.0558	CbGeAlD
Olopatadine—S100A12—blood—coronary artery disease	0.00155	0.0447	CbGeAlD
Olopatadine—S100B—blood—coronary artery disease	0.00153	0.0441	CbGeAlD
Olopatadine—S100A13—Alprenolol—Penbutolol—coronary artery disease	0.000728	0.234	CbGdCrCtD
Olopatadine—Clomipramine—HRH2—coronary artery disease	0.000438	0.137	CrCbGaD
Olopatadine—Doxepin—HRH2—coronary artery disease	0.000384	0.12	CrCbGaD
Olopatadine—Amitriptyline—HRH2—coronary artery disease	0.000297	0.0927	CrCbGaD
Olopatadine—CYP3A4—blood—coronary artery disease	0.000243	0.007	CbGeAlD
Olopatadine—Clomipramine—GSTP1—coronary artery disease	0.000182	0.0568	CrCbGaD
Olopatadine—Imipramine—SLC22A3—coronary artery disease	0.00016	0.05	CrCbGaD
Olopatadine—Amitriptyline—OPRD1—coronary artery disease	0.000157	0.0489	CrCbGaD
Olopatadine—Cyclobenzaprine—HTR2A—coronary artery disease	0.000143	0.0445	CrCbGaD
Olopatadine—Imipramine—HTR7—coronary artery disease	0.000102	0.0317	CrCbGaD
Olopatadine—Amitriptyline—HTR7—coronary artery disease	0.000101	0.0315	CrCbGaD
Olopatadine—Acepromazine—HTR2A—coronary artery disease	9.86e-05	0.0308	CrCbGaD
Olopatadine—Vomiting—Fenofibrate—coronary artery disease	9.56e-05	0.000614	CcSEcCtD
Olopatadine—Hypersensitivity—Valsartan—coronary artery disease	9.55e-05	0.000613	CcSEcCtD
Olopatadine—Body temperature increased—Trandolapril—coronary artery disease	9.53e-05	0.000612	CcSEcCtD
Olopatadine—Abdominal pain—Trandolapril—coronary artery disease	9.53e-05	0.000612	CcSEcCtD
Olopatadine—Dizziness—Ezetimibe—coronary artery disease	9.52e-05	0.000611	CcSEcCtD
Olopatadine—Body temperature increased—Enalapril—coronary artery disease	9.49e-05	0.000609	CcSEcCtD
Olopatadine—Abdominal pain—Enalapril—coronary artery disease	9.49e-05	0.000609	CcSEcCtD
Olopatadine—Feeling abnormal—Captopril—coronary artery disease	9.49e-05	0.000609	CcSEcCtD
Olopatadine—Thiothixene—HTR2A—coronary artery disease	9.48e-05	0.0296	CrCbGaD
Olopatadine—Rash—Fenofibrate—coronary artery disease	9.48e-05	0.000609	CcSEcCtD
Olopatadine—Dermatitis—Fenofibrate—coronary artery disease	9.47e-05	0.000608	CcSEcCtD
Olopatadine—Headache—Fenofibrate—coronary artery disease	9.42e-05	0.000605	CcSEcCtD
Olopatadine—Vision blurred—Lisinopril—coronary artery disease	9.42e-05	0.000605	CcSEcCtD
Olopatadine—Gastrointestinal pain—Captopril—coronary artery disease	9.42e-05	0.000605	CcSEcCtD
Olopatadine—Cough—Timolol—coronary artery disease	9.4e-05	0.000603	CcSEcCtD
Olopatadine—Vomiting—Clopidogrel—coronary artery disease	9.39e-05	0.000603	CcSEcCtD
Olopatadine—Diarrhoea—Simvastatin—coronary artery disease	9.39e-05	0.000603	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Furosemide—coronary artery disease	9.38e-05	0.000602	CcSEcCtD
Olopatadine—Fatigue—Furosemide—coronary artery disease	9.37e-05	0.000602	CcSEcCtD
Olopatadine—Body temperature increased—Telmisartan—coronary artery disease	9.36e-05	0.000601	CcSEcCtD
Olopatadine—Abdominal pain—Telmisartan—coronary artery disease	9.36e-05	0.000601	CcSEcCtD
Olopatadine—Dyspnoea—Losartan—coronary artery disease	9.35e-05	0.0006	CcSEcCtD
Olopatadine—Vomiting—Lovastatin—coronary artery disease	9.33e-05	0.000599	CcSEcCtD
Olopatadine—Somnolence—Losartan—coronary artery disease	9.32e-05	0.000598	CcSEcCtD
Olopatadine—Dizziness—Eplerenone—coronary artery disease	9.32e-05	0.000598	CcSEcCtD
Olopatadine—Rash—Clopidogrel—coronary artery disease	9.32e-05	0.000598	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	9.31e-05	0.000598	CcSEcCtD
Olopatadine—Dermatitis—Clopidogrel—coronary artery disease	9.31e-05	0.000598	CcSEcCtD
Olopatadine—Asthenia—Valsartan—coronary artery disease	9.3e-05	0.000597	CcSEcCtD
Olopatadine—Pain—Furosemide—coronary artery disease	9.29e-05	0.000597	CcSEcCtD
Olopatadine—Hypersensitivity—Niacin—coronary artery disease	9.29e-05	0.000596	CcSEcCtD
Olopatadine—Ill-defined disorder—Lisinopril—coronary artery disease	9.27e-05	0.000595	CcSEcCtD
Olopatadine—Discomfort—Ramipril—coronary artery disease	9.27e-05	0.000595	CcSEcCtD
Olopatadine—Asthenia—Olmesartan—coronary artery disease	9.26e-05	0.000594	CcSEcCtD
Olopatadine—Headache—Clopidogrel—coronary artery disease	9.26e-05	0.000594	CcSEcCtD
Olopatadine—Rash—Lovastatin—coronary artery disease	9.25e-05	0.000594	CcSEcCtD
Olopatadine—Clomipramine—CYP2C19—coronary artery disease	9.25e-05	0.0288	CrCbGaD
Olopatadine—Dermatitis—Lovastatin—coronary artery disease	9.25e-05	0.000594	CcSEcCtD
Olopatadine—Feeling abnormal—Perindopril—coronary artery disease	9.21e-05	0.000591	CcSEcCtD
Olopatadine—Headache—Lovastatin—coronary artery disease	9.2e-05	0.00059	CcSEcCtD
Olopatadine—Pruritus—Valsartan—coronary artery disease	9.17e-05	0.000589	CcSEcCtD
Olopatadine—Dry mouth—Ramipril—coronary artery disease	9.17e-05	0.000589	CcSEcCtD
Olopatadine—Vomiting—Ezetimibe—coronary artery disease	9.15e-05	0.000588	CcSEcCtD
Olopatadine—Hypersensitivity—Pravastatin—coronary artery disease	9.14e-05	0.000587	CcSEcCtD
Olopatadine—Gastrointestinal pain—Perindopril—coronary artery disease	9.14e-05	0.000587	CcSEcCtD
Olopatadine—Pruritus—Olmesartan—coronary artery disease	9.13e-05	0.000586	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.11e-05	0.000585	CcSEcCtD
Olopatadine—Body temperature increased—Captopril—coronary artery disease	9.1e-05	0.000584	CcSEcCtD
Olopatadine—Abdominal pain—Captopril—coronary artery disease	9.1e-05	0.000584	CcSEcCtD
Olopatadine—Dizziness—Simvastatin—coronary artery disease	9.08e-05	0.000583	CcSEcCtD
Olopatadine—Rash—Ezetimibe—coronary artery disease	9.08e-05	0.000583	CcSEcCtD
Olopatadine—Dermatitis—Ezetimibe—coronary artery disease	9.07e-05	0.000582	CcSEcCtD
Olopatadine—Discomfort—Timolol—coronary artery disease	9.06e-05	0.000582	CcSEcCtD
Olopatadine—Asthenia—Niacin—coronary artery disease	9.04e-05	0.000581	CcSEcCtD
Olopatadine—Fatigue—Losartan—coronary artery disease	9.04e-05	0.00058	CcSEcCtD
Olopatadine—Nortriptyline—CYP2C19—coronary artery disease	9.04e-05	0.0282	CrCbGaD
Olopatadine—Headache—Ezetimibe—coronary artery disease	9.02e-05	0.000579	CcSEcCtD
Olopatadine—Malaise—Lisinopril—coronary artery disease	9.01e-05	0.000578	CcSEcCtD
Olopatadine—Oedema—Ramipril—coronary artery disease	8.99e-05	0.000577	CcSEcCtD
Olopatadine—Dry mouth—Timolol—coronary artery disease	8.97e-05	0.000576	CcSEcCtD
Olopatadine—Pain—Losartan—coronary artery disease	8.97e-05	0.000576	CcSEcCtD
Olopatadine—Vomiting—Eplerenone—coronary artery disease	8.96e-05	0.000575	CcSEcCtD
Olopatadine—Feeling abnormal—Furosemide—coronary artery disease	8.96e-05	0.000575	CcSEcCtD
Olopatadine—Nausea—Fenofibrate—coronary artery disease	8.93e-05	0.000573	CcSEcCtD
Olopatadine—Pruritus—Niacin—coronary artery disease	8.92e-05	0.000573	CcSEcCtD
Olopatadine—Asthenia—Pravastatin—coronary artery disease	8.91e-05	0.000572	CcSEcCtD
Olopatadine—Gastrointestinal pain—Furosemide—coronary artery disease	8.89e-05	0.000571	CcSEcCtD
Olopatadine—Rash—Eplerenone—coronary artery disease	8.88e-05	0.00057	CcSEcCtD
Olopatadine—Hypersensitivity—Trandolapril—coronary artery disease	8.88e-05	0.00057	CcSEcCtD
Olopatadine—Dermatitis—Eplerenone—coronary artery disease	8.88e-05	0.00057	CcSEcCtD
Olopatadine—Diarrhoea—Valsartan—coronary artery disease	8.87e-05	0.00057	CcSEcCtD
Olopatadine—Hypersensitivity—Enalapril—coronary artery disease	8.84e-05	0.000568	CcSEcCtD
Olopatadine—Body temperature increased—Perindopril—coronary artery disease	8.84e-05	0.000567	CcSEcCtD
Olopatadine—Abdominal pain—Perindopril—coronary artery disease	8.84e-05	0.000567	CcSEcCtD
Olopatadine—Diarrhoea—Olmesartan—coronary artery disease	8.83e-05	0.000567	CcSEcCtD
Olopatadine—Headache—Eplerenone—coronary artery disease	8.83e-05	0.000567	CcSEcCtD
Olopatadine—Nervous system disorder—Ramipril—coronary artery disease	8.82e-05	0.000566	CcSEcCtD
Olopatadine—Oedema—Timolol—coronary artery disease	8.79e-05	0.000564	CcSEcCtD
Olopatadine—Pruritus—Pravastatin—coronary artery disease	8.78e-05	0.000564	CcSEcCtD
Olopatadine—Nausea—Clopidogrel—coronary artery disease	8.78e-05	0.000563	CcSEcCtD
Olopatadine—Skin disorder—Ramipril—coronary artery disease	8.73e-05	0.000561	CcSEcCtD
Olopatadine—Infection—Timolol—coronary artery disease	8.73e-05	0.000561	CcSEcCtD
Olopatadine—Vomiting—Simvastatin—coronary artery disease	8.73e-05	0.00056	CcSEcCtD
Olopatadine—Hypersensitivity—Telmisartan—coronary artery disease	8.72e-05	0.00056	CcSEcCtD
Olopatadine—Cough—Lisinopril—coronary artery disease	8.72e-05	0.00056	CcSEcCtD
Olopatadine—Nausea—Lovastatin—coronary artery disease	8.72e-05	0.00056	CcSEcCtD
Olopatadine—Rash—Simvastatin—coronary artery disease	8.66e-05	0.000556	CcSEcCtD
Olopatadine—Dermatitis—Simvastatin—coronary artery disease	8.65e-05	0.000555	CcSEcCtD
Olopatadine—Asthenia—Trandolapril—coronary artery disease	8.65e-05	0.000555	CcSEcCtD
Olopatadine—Feeling abnormal—Losartan—coronary artery disease	8.64e-05	0.000555	CcSEcCtD
Olopatadine—Diarrhoea—Niacin—coronary artery disease	8.63e-05	0.000554	CcSEcCtD
Olopatadine—Nervous system disorder—Timolol—coronary artery disease	8.62e-05	0.000553	CcSEcCtD
Olopatadine—Asthenia—Enalapril—coronary artery disease	8.61e-05	0.000553	CcSEcCtD
Olopatadine—Headache—Simvastatin—coronary artery disease	8.6e-05	0.000552	CcSEcCtD
Olopatadine—Abdominal pain—Furosemide—coronary artery disease	8.59e-05	0.000552	CcSEcCtD
Olopatadine—Body temperature increased—Furosemide—coronary artery disease	8.59e-05	0.000552	CcSEcCtD
Olopatadine—Gastrointestinal pain—Losartan—coronary artery disease	8.57e-05	0.000551	CcSEcCtD
Olopatadine—Dizziness—Valsartan—coronary artery disease	8.57e-05	0.00055	CcSEcCtD
Olopatadine—Nausea—Ezetimibe—coronary artery disease	8.55e-05	0.000549	CcSEcCtD
Olopatadine—Skin disorder—Timolol—coronary artery disease	8.54e-05	0.000548	CcSEcCtD
Olopatadine—Dizziness—Olmesartan—coronary artery disease	8.53e-05	0.000548	CcSEcCtD
Olopatadine—Pruritus—Trandolapril—coronary artery disease	8.53e-05	0.000548	CcSEcCtD
Olopatadine—Asthenia—Telmisartan—coronary artery disease	8.5e-05	0.000545	CcSEcCtD
Olopatadine—Pruritus—Enalapril—coronary artery disease	8.49e-05	0.000545	CcSEcCtD
Olopatadine—Diarrhoea—Pravastatin—coronary artery disease	8.49e-05	0.000545	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.45e-05	0.000542	CcSEcCtD
Olopatadine—Discomfort—Lisinopril—coronary artery disease	8.4e-05	0.00054	CcSEcCtD
Olopatadine—Pruritus—Telmisartan—coronary artery disease	8.38e-05	0.000538	CcSEcCtD
Olopatadine—Nausea—Eplerenone—coronary artery disease	8.37e-05	0.000537	CcSEcCtD
Olopatadine—Dizziness—Niacin—coronary artery disease	8.34e-05	0.000535	CcSEcCtD
Olopatadine—Dry mouth—Lisinopril—coronary artery disease	8.32e-05	0.000534	CcSEcCtD
Olopatadine—Body temperature increased—Losartan—coronary artery disease	8.29e-05	0.000532	CcSEcCtD
Olopatadine—Abdominal pain—Losartan—coronary artery disease	8.29e-05	0.000532	CcSEcCtD
Olopatadine—Asthenia—Captopril—coronary artery disease	8.26e-05	0.00053	CcSEcCtD
Olopatadine—Diarrhoea—Trandolapril—coronary artery disease	8.25e-05	0.000529	CcSEcCtD
Olopatadine—Vomiting—Valsartan—coronary artery disease	8.24e-05	0.000529	CcSEcCtD
Olopatadine—Diarrhoea—Enalapril—coronary artery disease	8.21e-05	0.000527	CcSEcCtD
Olopatadine—Dizziness—Pravastatin—coronary artery disease	8.21e-05	0.000527	CcSEcCtD
Olopatadine—Vomiting—Olmesartan—coronary artery disease	8.2e-05	0.000527	CcSEcCtD
Olopatadine—Rash—Valsartan—coronary artery disease	8.17e-05	0.000525	CcSEcCtD
Olopatadine—Dermatitis—Valsartan—coronary artery disease	8.17e-05	0.000524	CcSEcCtD
Olopatadine—Nausea—Simvastatin—coronary artery disease	8.16e-05	0.000524	CcSEcCtD
Olopatadine—Oedema—Lisinopril—coronary artery disease	8.15e-05	0.000524	CcSEcCtD
Olopatadine—Pruritus—Captopril—coronary artery disease	8.15e-05	0.000523	CcSEcCtD
Olopatadine—Rash—Olmesartan—coronary artery disease	8.14e-05	0.000522	CcSEcCtD
Olopatadine—Dermatitis—Olmesartan—coronary artery disease	8.13e-05	0.000522	CcSEcCtD
Olopatadine—Headache—Valsartan—coronary artery disease	8.12e-05	0.000521	CcSEcCtD
Olopatadine—Doxepin—CYP2C19—coronary artery disease	8.11e-05	0.0253	CrCbGaD
Olopatadine—Diarrhoea—Telmisartan—coronary artery disease	8.1e-05	0.00052	CcSEcCtD
Olopatadine—Infection—Lisinopril—coronary artery disease	8.1e-05	0.00052	CcSEcCtD
Olopatadine—Headache—Olmesartan—coronary artery disease	8.08e-05	0.000519	CcSEcCtD
Olopatadine—Asthenia—Perindopril—coronary artery disease	8.02e-05	0.000515	CcSEcCtD
Olopatadine—Dyspnoea—Ramipril—coronary artery disease	8.02e-05	0.000515	CcSEcCtD
Olopatadine—Vomiting—Niacin—coronary artery disease	8.02e-05	0.000515	CcSEcCtD
Olopatadine—Hypersensitivity—Furosemide—coronary artery disease	8.01e-05	0.000514	CcSEcCtD
Olopatadine—Somnolence—Ramipril—coronary artery disease	7.99e-05	0.000513	CcSEcCtD
Olopatadine—Dizziness—Trandolapril—coronary artery disease	7.97e-05	0.000512	CcSEcCtD
Olopatadine—Rash—Niacin—coronary artery disease	7.95e-05	0.00051	CcSEcCtD
Olopatadine—Dermatitis—Niacin—coronary artery disease	7.94e-05	0.00051	CcSEcCtD
Olopatadine—Dizziness—Enalapril—coronary artery disease	7.94e-05	0.00051	CcSEcCtD
Olopatadine—Skin disorder—Lisinopril—coronary artery disease	7.92e-05	0.000509	CcSEcCtD
Olopatadine—Pruritus—Perindopril—coronary artery disease	7.91e-05	0.000508	CcSEcCtD
Olopatadine—Headache—Niacin—coronary artery disease	7.9e-05	0.000507	CcSEcCtD
Olopatadine—Vomiting—Pravastatin—coronary artery disease	7.89e-05	0.000507	CcSEcCtD
Olopatadine—Diarrhoea—Captopril—coronary artery disease	7.88e-05	0.000506	CcSEcCtD
Olopatadine—Dyspnoea—Timolol—coronary artery disease	7.84e-05	0.000503	CcSEcCtD
Olopatadine—Dizziness—Telmisartan—coronary artery disease	7.83e-05	0.000503	CcSEcCtD
Olopatadine—Rash—Pravastatin—coronary artery disease	7.83e-05	0.000502	CcSEcCtD
Olopatadine—Dermatitis—Pravastatin—coronary artery disease	7.82e-05	0.000502	CcSEcCtD
Olopatadine—Somnolence—Timolol—coronary artery disease	7.81e-05	0.000502	CcSEcCtD
Olopatadine—Asthenia—Furosemide—coronary artery disease	7.8e-05	0.000501	CcSEcCtD
Olopatadine—Headache—Pravastatin—coronary artery disease	7.78e-05	0.000499	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Ramipril—coronary artery disease	7.76e-05	0.000498	CcSEcCtD
Olopatadine—Fatigue—Ramipril—coronary artery disease	7.75e-05	0.000498	CcSEcCtD
Olopatadine—Hypersensitivity—Losartan—coronary artery disease	7.73e-05	0.000496	CcSEcCtD
Olopatadine—Nausea—Valsartan—coronary artery disease	7.7e-05	0.000494	CcSEcCtD
Olopatadine—Pruritus—Furosemide—coronary artery disease	7.69e-05	0.000494	CcSEcCtD
Olopatadine—Nausea—Olmesartan—coronary artery disease	7.66e-05	0.000492	CcSEcCtD
Olopatadine—Vomiting—Trandolapril—coronary artery disease	7.66e-05	0.000492	CcSEcCtD
Olopatadine—Diarrhoea—Perindopril—coronary artery disease	7.65e-05	0.000491	CcSEcCtD
Olopatadine—Vomiting—Enalapril—coronary artery disease	7.63e-05	0.00049	CcSEcCtD
Olopatadine—Dizziness—Captopril—coronary artery disease	7.61e-05	0.000489	CcSEcCtD
Olopatadine—Rash—Trandolapril—coronary artery disease	7.6e-05	0.000488	CcSEcCtD
Olopatadine—Dermatitis—Trandolapril—coronary artery disease	7.59e-05	0.000487	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Timolol—coronary artery disease	7.59e-05	0.000487	CcSEcCtD
Olopatadine—Fatigue—Timolol—coronary artery disease	7.58e-05	0.000487	CcSEcCtD
Olopatadine—Rash—Enalapril—coronary artery disease	7.57e-05	0.000486	CcSEcCtD
Olopatadine—Dermatitis—Enalapril—coronary artery disease	7.56e-05	0.000486	CcSEcCtD
Olopatadine—Headache—Trandolapril—coronary artery disease	7.55e-05	0.000485	CcSEcCtD
Olopatadine—Vomiting—Telmisartan—coronary artery disease	7.53e-05	0.000483	CcSEcCtD
Olopatadine—Asthenia—Losartan—coronary artery disease	7.52e-05	0.000483	CcSEcCtD
Olopatadine—Headache—Enalapril—coronary artery disease	7.52e-05	0.000483	CcSEcCtD
Olopatadine—Pain—Timolol—coronary artery disease	7.52e-05	0.000483	CcSEcCtD
Olopatadine—Clomipramine—HTR2A—coronary artery disease	7.5e-05	0.0234	CrCbGaD
Olopatadine—Nausea—Niacin—coronary artery disease	7.49e-05	0.000481	CcSEcCtD
Olopatadine—Rash—Telmisartan—coronary artery disease	7.47e-05	0.000479	CcSEcCtD
Olopatadine—Chlorprothixene—HTR2A—coronary artery disease	7.46e-05	0.0233	CrCbGaD
Olopatadine—Dermatitis—Telmisartan—coronary artery disease	7.46e-05	0.000479	CcSEcCtD
Olopatadine—Diarrhoea—Furosemide—coronary artery disease	7.44e-05	0.000477	CcSEcCtD
Olopatadine—Pruritus—Losartan—coronary artery disease	7.42e-05	0.000476	CcSEcCtD
Olopatadine—Headache—Telmisartan—coronary artery disease	7.42e-05	0.000476	CcSEcCtD
Olopatadine—Feeling abnormal—Ramipril—coronary artery disease	7.41e-05	0.000476	CcSEcCtD
Olopatadine—Dizziness—Perindopril—coronary artery disease	7.39e-05	0.000475	CcSEcCtD
Olopatadine—Nausea—Pravastatin—coronary artery disease	7.37e-05	0.000473	CcSEcCtD
Olopatadine—Gastrointestinal pain—Ramipril—coronary artery disease	7.35e-05	0.000472	CcSEcCtD
Olopatadine—Nortriptyline—HTR2A—coronary artery disease	7.33e-05	0.0228	CrCbGaD
Olopatadine—Vomiting—Captopril—coronary artery disease	7.32e-05	0.00047	CcSEcCtD
Olopatadine—Dyspnoea—Lisinopril—coronary artery disease	7.27e-05	0.000467	CcSEcCtD
Olopatadine—Rash—Captopril—coronary artery disease	7.26e-05	0.000466	CcSEcCtD
Olopatadine—Dermatitis—Captopril—coronary artery disease	7.25e-05	0.000466	CcSEcCtD
Olopatadine—Somnolence—Lisinopril—coronary artery disease	7.25e-05	0.000465	CcSEcCtD
Olopatadine—Feeling abnormal—Timolol—coronary artery disease	7.24e-05	0.000465	CcSEcCtD
Olopatadine—Headache—Captopril—coronary artery disease	7.21e-05	0.000463	CcSEcCtD
Olopatadine—Gastrointestinal pain—Timolol—coronary artery disease	7.19e-05	0.000461	CcSEcCtD
Olopatadine—Dizziness—Furosemide—coronary artery disease	7.19e-05	0.000461	CcSEcCtD
Olopatadine—Diarrhoea—Losartan—coronary artery disease	7.17e-05	0.000461	CcSEcCtD
Olopatadine—Nausea—Trandolapril—coronary artery disease	7.16e-05	0.00046	CcSEcCtD
Olopatadine—Nausea—Enalapril—coronary artery disease	7.13e-05	0.000458	CcSEcCtD
Olopatadine—Vomiting—Perindopril—coronary artery disease	7.11e-05	0.000456	CcSEcCtD
Olopatadine—Body temperature increased—Ramipril—coronary artery disease	7.11e-05	0.000456	CcSEcCtD
Olopatadine—Abdominal pain—Ramipril—coronary artery disease	7.11e-05	0.000456	CcSEcCtD
Olopatadine—Rash—Perindopril—coronary artery disease	7.05e-05	0.000453	CcSEcCtD
Olopatadine—Dermatitis—Perindopril—coronary artery disease	7.04e-05	0.000452	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.04e-05	0.000452	CcSEcCtD
Olopatadine—Nausea—Telmisartan—coronary artery disease	7.03e-05	0.000452	CcSEcCtD
Olopatadine—Fatigue—Lisinopril—coronary artery disease	7.03e-05	0.000451	CcSEcCtD
Olopatadine—Headache—Perindopril—coronary artery disease	7e-05	0.00045	CcSEcCtD
Olopatadine—Pain—Lisinopril—coronary artery disease	6.97e-05	0.000448	CcSEcCtD
Olopatadine—Abdominal pain—Timolol—coronary artery disease	6.95e-05	0.000446	CcSEcCtD
Olopatadine—Body temperature increased—Timolol—coronary artery disease	6.95e-05	0.000446	CcSEcCtD
Olopatadine—Dizziness—Losartan—coronary artery disease	6.93e-05	0.000445	CcSEcCtD
Olopatadine—Vomiting—Furosemide—coronary artery disease	6.91e-05	0.000444	CcSEcCtD
Olopatadine—Rash—Furosemide—coronary artery disease	6.85e-05	0.00044	CcSEcCtD
Olopatadine—Dermatitis—Furosemide—coronary artery disease	6.85e-05	0.00044	CcSEcCtD
Olopatadine—Nausea—Captopril—coronary artery disease	6.84e-05	0.000439	CcSEcCtD
Olopatadine—Headache—Furosemide—coronary artery disease	6.81e-05	0.000437	CcSEcCtD
Olopatadine—Acepromazine—ALB—coronary artery disease	6.75e-05	0.021	CrCbGaD
Olopatadine—Feeling abnormal—Lisinopril—coronary artery disease	6.72e-05	0.000431	CcSEcCtD
Olopatadine—Gastrointestinal pain—Lisinopril—coronary artery disease	6.67e-05	0.000428	CcSEcCtD
Olopatadine—Vomiting—Losartan—coronary artery disease	6.67e-05	0.000428	CcSEcCtD
Olopatadine—Nausea—Perindopril—coronary artery disease	6.64e-05	0.000426	CcSEcCtD
Olopatadine—Hypersensitivity—Ramipril—coronary artery disease	6.62e-05	0.000425	CcSEcCtD
Olopatadine—Rash—Losartan—coronary artery disease	6.61e-05	0.000424	CcSEcCtD
Olopatadine—Dermatitis—Losartan—coronary artery disease	6.61e-05	0.000424	CcSEcCtD
Olopatadine—Doxepin—HTR2A—coronary artery disease	6.57e-05	0.0205	CrCbGaD
Olopatadine—Headache—Losartan—coronary artery disease	6.57e-05	0.000422	CcSEcCtD
Olopatadine—Thiothixene—ALB—coronary artery disease	6.49e-05	0.0202	CrCbGaD
Olopatadine—Hypersensitivity—Timolol—coronary artery disease	6.48e-05	0.000416	CcSEcCtD
Olopatadine—Nausea—Furosemide—coronary artery disease	6.46e-05	0.000414	CcSEcCtD
Olopatadine—Asthenia—Ramipril—coronary artery disease	6.45e-05	0.000414	CcSEcCtD
Olopatadine—Abdominal pain—Lisinopril—coronary artery disease	6.45e-05	0.000414	CcSEcCtD
Olopatadine—Body temperature increased—Lisinopril—coronary artery disease	6.45e-05	0.000414	CcSEcCtD
Olopatadine—Pruritus—Ramipril—coronary artery disease	6.36e-05	0.000408	CcSEcCtD
Olopatadine—Imipramine—CYP2C19—coronary artery disease	6.31e-05	0.0197	CrCbGaD
Olopatadine—Asthenia—Timolol—coronary artery disease	6.31e-05	0.000405	CcSEcCtD
Olopatadine—Amitriptyline—CYP2C19—coronary artery disease	6.27e-05	0.0196	CrCbGaD
Olopatadine—Nausea—Losartan—coronary artery disease	6.23e-05	0.0004	CcSEcCtD
Olopatadine—Pruritus—Timolol—coronary artery disease	6.22e-05	0.000399	CcSEcCtD
Olopatadine—Diarrhoea—Ramipril—coronary artery disease	6.15e-05	0.000395	CcSEcCtD
Olopatadine—Diarrhoea—Timolol—coronary artery disease	6.01e-05	0.000386	CcSEcCtD
Olopatadine—Hypersensitivity—Lisinopril—coronary artery disease	6.01e-05	0.000386	CcSEcCtD
Olopatadine—Dizziness—Ramipril—coronary artery disease	5.95e-05	0.000382	CcSEcCtD
Olopatadine—Asthenia—Lisinopril—coronary artery disease	5.85e-05	0.000376	CcSEcCtD
Olopatadine—Dizziness—Timolol—coronary artery disease	5.81e-05	0.000373	CcSEcCtD
Olopatadine—Pruritus—Lisinopril—coronary artery disease	5.77e-05	0.00037	CcSEcCtD
Olopatadine—Vomiting—Ramipril—coronary artery disease	5.72e-05	0.000367	CcSEcCtD
Olopatadine—Rash—Ramipril—coronary artery disease	5.67e-05	0.000364	CcSEcCtD
Olopatadine—Dermatitis—Ramipril—coronary artery disease	5.66e-05	0.000364	CcSEcCtD
Olopatadine—Headache—Ramipril—coronary artery disease	5.63e-05	0.000362	CcSEcCtD
Olopatadine—Vomiting—Timolol—coronary artery disease	5.59e-05	0.000359	CcSEcCtD
Olopatadine—Diarrhoea—Lisinopril—coronary artery disease	5.58e-05	0.000358	CcSEcCtD
Olopatadine—Rash—Timolol—coronary artery disease	5.54e-05	0.000356	CcSEcCtD
Olopatadine—Dermatitis—Timolol—coronary artery disease	5.54e-05	0.000355	CcSEcCtD
Olopatadine—Headache—Timolol—coronary artery disease	5.51e-05	0.000354	CcSEcCtD
Olopatadine—Dizziness—Lisinopril—coronary artery disease	5.39e-05	0.000346	CcSEcCtD
Olopatadine—Nausea—Ramipril—coronary artery disease	5.34e-05	0.000343	CcSEcCtD
Olopatadine—Nausea—Timolol—coronary artery disease	5.22e-05	0.000335	CcSEcCtD
Olopatadine—Vomiting—Lisinopril—coronary artery disease	5.18e-05	0.000333	CcSEcCtD
Olopatadine—Rash—Lisinopril—coronary artery disease	5.14e-05	0.00033	CcSEcCtD
Olopatadine—Dermatitis—Lisinopril—coronary artery disease	5.14e-05	0.00033	CcSEcCtD
Olopatadine—Clomipramine—ALB—coronary artery disease	5.13e-05	0.016	CrCbGaD
Olopatadine—Imipramine—HTR2A—coronary artery disease	5.12e-05	0.0159	CrCbGaD
Olopatadine—Headache—Lisinopril—coronary artery disease	5.11e-05	0.000328	CcSEcCtD
Olopatadine—Amitriptyline—HTR2A—coronary artery disease	5.08e-05	0.0159	CrCbGaD
Olopatadine—Nortriptyline—ALB—coronary artery disease	5.01e-05	0.0156	CrCbGaD
Olopatadine—Nausea—Lisinopril—coronary artery disease	4.84e-05	0.000311	CcSEcCtD
Olopatadine—Amitriptyline—ALB—coronary artery disease	3.48e-05	0.0108	CrCbGaD
Olopatadine—HRH1—Signaling Pathways—HDAC9—coronary artery disease	6.95e-06	5.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLCB3—coronary artery disease	6.95e-06	5.53e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL8—coronary artery disease	6.94e-06	5.52e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CX3CR1—coronary artery disease	6.88e-06	5.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASR—coronary artery disease	6.88e-06	5.47e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SULT4A1—coronary artery disease	6.83e-06	5.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PYGM—coronary artery disease	6.83e-06	5.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PDK4—coronary artery disease	6.83e-06	5.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CKMT2—coronary artery disease	6.83e-06	5.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	6.83e-06	5.43e-05	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CA—coronary artery disease	6.81e-06	5.41e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—POMC—coronary artery disease	6.8e-06	5.41e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRB2—coronary artery disease	6.79e-06	5.4e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—P4HB—coronary artery disease	6.75e-06	5.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BDKRB1—coronary artery disease	6.75e-06	5.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CX3CL1—coronary artery disease	6.75e-06	5.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GNA12—coronary artery disease	6.75e-06	5.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCE—coronary artery disease	6.71e-06	5.33e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—EDN1—coronary artery disease	6.68e-06	5.32e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP3—coronary artery disease	6.64e-06	5.28e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCL5—coronary artery disease	6.63e-06	5.27e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PPP3R1—coronary artery disease	6.62e-06	5.27e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADM—coronary artery disease	6.56e-06	5.22e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CSF2—coronary artery disease	6.53e-06	5.2e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCND1—coronary artery disease	6.46e-06	5.14e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDE4B—coronary artery disease	6.4e-06	5.09e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CYBB—coronary artery disease	6.4e-06	5.09e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL8—coronary artery disease	6.39e-06	5.08e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MMP3—coronary artery disease	6.38e-06	5.08e-05	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—coronary artery disease	6.38e-06	5.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	6.37e-06	5.06e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—coronary artery disease	6.28e-06	4.99e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMGCS2—coronary artery disease	6.08e-06	4.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GK—coronary artery disease	6.08e-06	4.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LDHA—coronary artery disease	6.08e-06	4.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GYG1—coronary artery disease	6.08e-06	4.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PFKM—coronary artery disease	6.08e-06	4.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GATM—coronary artery disease	6.08e-06	4.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EDN1—coronary artery disease	6.07e-06	4.83e-05	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—coronary artery disease	6.03e-06	4.79e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL5—coronary artery disease	6.02e-06	4.79e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PRKCD—coronary artery disease	5.97e-06	4.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CSF2—coronary artery disease	5.93e-06	4.72e-05	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—coronary artery disease	5.88e-06	4.68e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR3—coronary artery disease	5.85e-06	4.65e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2A—coronary artery disease	5.85e-06	4.65e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—C3—coronary artery disease	5.84e-06	4.64e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCH1—coronary artery disease	5.8e-06	4.62e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AK1—coronary artery disease	5.8e-06	4.62e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CRK—coronary artery disease	5.77e-06	4.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SH2B3—coronary artery disease	5.7e-06	4.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VWF—coronary artery disease	5.7e-06	4.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ATP2A2—coronary artery disease	5.7e-06	4.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOC3—coronary artery disease	5.67e-06	4.51e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—coronary artery disease	5.64e-06	4.48e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LDLR—coronary artery disease	5.63e-06	4.48e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPAT—coronary artery disease	5.56e-06	4.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLCD1—coronary artery disease	5.56e-06	4.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MDH2—coronary artery disease	5.56e-06	4.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UGCG—coronary artery disease	5.56e-06	4.43e-05	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—coronary artery disease	5.56e-06	4.42e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AGT—coronary artery disease	5.55e-06	4.41e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PPP2CA—coronary artery disease	5.53e-06	4.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL3—coronary artery disease	5.5e-06	4.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL2—coronary artery disease	5.5e-06	4.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2R—coronary artery disease	5.44e-06	4.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SDC1—coronary artery disease	5.44e-06	4.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCD—coronary artery disease	5.43e-06	4.32e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PGM1—coronary artery disease	5.36e-06	4.26e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGB—coronary artery disease	5.32e-06	4.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2A—coronary artery disease	5.31e-06	4.22e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—C3—coronary artery disease	5.3e-06	4.22e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDNRB—coronary artery disease	5.27e-06	4.19e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—THBS1—coronary artery disease	5.19e-06	4.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PYGB—coronary artery disease	5.17e-06	4.11e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CKB—coronary artery disease	5.17e-06	4.11e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—coronary artery disease	5.17e-06	4.11e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PSMA6—coronary artery disease	5.14e-06	4.09e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PSMB5—coronary artery disease	5.14e-06	4.09e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—F2—coronary artery disease	5.13e-06	4.08e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK1—coronary artery disease	5.07e-06	4.03e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AGT—coronary artery disease	5.04e-06	4.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDNRA—coronary artery disease	4.97e-06	3.96e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CYBA—coronary artery disease	4.95e-06	3.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB1—coronary artery disease	4.95e-06	3.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DUSP6—coronary artery disease	4.93e-06	3.92e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM2—coronary artery disease	4.86e-06	3.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—COX5B—coronary artery disease	4.86e-06	3.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLIN1—coronary artery disease	4.86e-06	3.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DLAT—coronary artery disease	4.86e-06	3.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	4.86e-06	3.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLAT—coronary artery disease	4.85e-06	3.86e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL12—coronary artery disease	4.68e-06	3.72e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BDKRB2—coronary artery disease	4.68e-06	3.72e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—POMC—coronary artery disease	4.67e-06	3.71e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—F2—coronary artery disease	4.66e-06	3.7e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6ST—coronary artery disease	4.64e-06	3.69e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	4.61e-06	3.67e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUNB—coronary artery disease	4.59e-06	3.65e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLCB1—coronary artery disease	4.57e-06	3.64e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR7—coronary artery disease	4.48e-06	3.56e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CA—coronary artery disease	4.4e-06	3.5e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HK2—coronary artery disease	4.4e-06	3.5e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	4.4e-06	3.5e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ITGAV—coronary artery disease	4.27e-06	3.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KNG1—coronary artery disease	4.25e-06	3.38e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—POMC—coronary artery disease	4.24e-06	3.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CREB1—coronary artery disease	4.24e-06	3.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGTR1—coronary artery disease	4.23e-06	3.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.22e-06	3.35e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL2—coronary artery disease	4.15e-06	3.3e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6R—coronary artery disease	4.14e-06	3.29e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.14e-06	3.29e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LCAT—coronary artery disease	4.14e-06	3.29e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL10—coronary artery disease	4.13e-06	3.29e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLG—coronary artery disease	4.12e-06	3.28e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA4—coronary artery disease	4.06e-06	3.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB2—coronary artery disease	4.01e-06	3.19e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCE—coronary artery disease	3.96e-06	3.15e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—JAK2—coronary artery disease	3.96e-06	3.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SOCS1—coronary artery disease	3.95e-06	3.14e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—S100B—coronary artery disease	3.94e-06	3.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.92e-06	3.12e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCLM—coronary artery disease	3.92e-06	3.12e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SOCS3—coronary artery disease	3.9e-06	3.1e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—coronary artery disease	3.9e-06	3.1e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KITLG—coronary artery disease	3.86e-06	3.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	3.86e-06	3.07e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.8e-06	3.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.8e-06	3.02e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP3—coronary artery disease	3.77e-06	3e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT5A—coronary artery disease	3.77e-06	3e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.74e-06	2.97e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.69e-06	2.93e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HADH—coronary artery disease	3.69e-06	2.93e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOB—coronary artery disease	3.64e-06	2.9e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	3.61e-06	2.87e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—coronary artery disease	3.6e-06	2.86e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	3.59e-06	2.86e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDN1—coronary artery disease	3.59e-06	2.85e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL5—coronary artery disease	3.56e-06	2.83e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CSF2—coronary artery disease	3.5e-06	2.79e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGF1—coronary artery disease	3.5e-06	2.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPX2—coronary artery disease	3.49e-06	2.78e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA2—coronary artery disease	3.49e-06	2.78e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.49e-06	2.78e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LPL—coronary artery disease	3.48e-06	2.77e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HK1—coronary artery disease	3.45e-06	2.75e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.45e-06	2.75e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPX4—coronary artery disease	3.45e-06	2.75e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.45e-06	2.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	3.45e-06	2.74e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	3.45e-06	2.74e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HADHA—coronary artery disease	3.41e-06	2.71e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.37e-06	2.68e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	3.36e-06	2.67e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPA—coronary artery disease	3.33e-06	2.65e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	3.28e-06	2.61e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	3.26e-06	2.6e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.23e-06	2.57e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	3.21e-06	2.55e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA5—coronary artery disease	3.2e-06	2.54e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	3.14e-06	2.49e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—P4HB—coronary artery disease	3.13e-06	2.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—C3—coronary artery disease	3.13e-06	2.49e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.08e-06	2.45e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	2.99e-06	2.38e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGT—coronary artery disease	2.98e-06	2.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—coronary artery disease	2.92e-06	2.32e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LEP—coronary artery disease	2.92e-06	2.32e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—VCAN—coronary artery disease	2.9e-06	2.31e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOA1—coronary artery disease	2.88e-06	2.29e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.88e-06	2.29e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KDR—coronary artery disease	2.86e-06	2.27e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	2.84e-06	2.26e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DCN—coronary artery disease	2.79e-06	2.22e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ESR1—coronary artery disease	2.78e-06	2.21e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2—coronary artery disease	2.75e-06	2.19e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FN1—coronary artery disease	2.75e-06	2.19e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	2.74e-06	2.18e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.72e-06	2.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	2.72e-06	2.16e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.65e-06	2.11e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.65e-06	2.11e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LIPC—coronary artery disease	2.65e-06	2.11e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HBA1—coronary artery disease	2.65e-06	2.11e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOC3—coronary artery disease	2.63e-06	2.09e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KIT—coronary artery disease	2.63e-06	2.09e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LDLR—coronary artery disease	2.62e-06	2.08e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.58e-06	2.06e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.58e-06	2.06e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCLC—coronary artery disease	2.55e-06	2.03e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CETP—coronary artery disease	2.55e-06	2.03e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SDC1—coronary artery disease	2.53e-06	2.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	2.53e-06	2.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—POMC—coronary artery disease	2.51e-06	1.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CREB1—coronary artery disease	2.51e-06	1.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL2—coronary artery disease	2.45e-06	1.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6R—coronary artery disease	2.44e-06	1.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1—coronary artery disease	2.41e-06	1.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	2.4e-06	1.91e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.39e-06	1.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.39e-06	1.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CTGF—coronary artery disease	2.33e-06	1.85e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.31e-06	1.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT2—coronary artery disease	2.31e-06	1.84e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.29e-06	1.82e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	2.29e-06	1.82e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.22e-06	1.76e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.18e-06	1.74e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.12e-06	1.69e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.12e-06	1.69e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2.08e-06	1.66e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.06e-06	1.64e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GGT1—coronary artery disease	1.99e-06	1.59e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT1—coronary artery disease	1.99e-06	1.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.94e-06	1.54e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.87e-06	1.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.85e-06	1.48e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.84e-06	1.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.81e-06	1.44e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.79e-06	1.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.77e-06	1.41e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.77e-06	1.41e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.75e-06	1.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAT—coronary artery disease	1.74e-06	1.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.7e-06	1.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOB—coronary artery disease	1.69e-06	1.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.65e-06	1.31e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPL—coronary artery disease	1.62e-06	1.29e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPX1—coronary artery disease	1.58e-06	1.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.57e-06	1.25e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CD36—coronary artery disease	1.54e-06	1.22e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.52e-06	1.21e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.46e-06	1.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.44e-06	1.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.42e-06	1.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AGT—coronary artery disease	1.38e-06	1.1e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—coronary artery disease	1.35e-06	1.08e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.34e-06	1.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.23e-06	9.78e-06	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.18e-06	9.38e-06	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—POMC—coronary artery disease	1.16e-06	9.26e-06	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.09e-06	8.66e-06	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—coronary artery disease	1.06e-06	8.44e-06	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.01e-06	8.07e-06	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—coronary artery disease	1e-06	7.99e-06	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—coronary artery disease	9.28e-07	7.38e-06	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.71e-07	4.54e-06	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—coronary artery disease	4.66e-07	3.71e-06	CbGpPWpGaD
